Introduction
The proportion of tuberculosis-infected people in the world population is about one third, which is responsible for a high rate of mortality [1, 2] . Mycobacterium tuberculosis, which is the causative pathogen of tuberculosis, is an acid-fast, slow-growing bacterium. The immune responses mounted by the human body against this pathogen contain the growth of the pathogen but fail to provide sterile immunity. Mortality and morbidity from tuberculosis continue to rise because of drug resistance and coinfection of M. tuberculosis and HIV. Pathogens have evolved many strategies to adapt, survive, and reproduce inside the host. These strategies involve active interventions into host immune regulatory mechanisms, such as hijacking the host cell machinery and molecular piracy [3] . Molecular piracy/mimicry is one such strategy wherein pathogens incorporate sequences of host proteins in their genomes and, when expressed, sequester signaling intermediates and modulate immune responses.
Molecular mimicry has recently been demonstrated to be a potent immune-evasion mechanism in certain uropathogenic strains of Escherichia coli [4] . Virulent bacteria interfere directly with TLR functions by secreting inhibitory homologs of the TIR domain [4] . TLRs are a critical component of the innate arm of the immune system and are directly responsible for the generation of proinflammatory responses [5, 6] . Upon activation of the TLR, the adaptor protein MyD88 is recruited, which in turn, recruits IRAK1 and IRAK4. IRAK4 subsequently phosphorylates and activates IRAK1. Both IRAK1 and IRAK4 dissociate from the MyD88-TLR complex and associate temporarily with TRAF6 leading to its ubiquitination [7] . Activation of TLR signaling culminates in NF-kB and MAPK activation, which regulate gene expression of various immune and inflammatory mediators, resulting in the production of inflammatory cytokines [8] . Escherichia coli CFT073 and Brucella melitensis harbor genes encoding TcpC and TcpB, respectively. TcpC is expressed by the some of the most virulent, uropathogenic strains of E. coli, which promote bacterial survival and modulate renal pathology in the host. In addition, significant tertiary-structure homology to the TIR domain of human TLR1 is shown by TcpC. Tcp binds directly to MyD88 and inhibits TLR-and MyD88-specific signaling, thus suppressing innate immunity and increasing virulence [4] .
With that understanding, we hypothesized that M. tuberculosis might also harbor proteins that are structurally similar to the TLRs or the TLR pathway adaptor proteins, which might subsequently interfere with their signaling and regulation of immune responses. Bioinformatic analyses of the M. tuberculosis genome identified one such gene, Rv3529c, which showed significant sequence and structural identity with the death domain of MyD88. Stimulation of Mfs with recombinant Rv3529c inhibited TLR2 responses with a reduction in ROS generation, phosphorylation of ERK-MAPK, activation of NFkB, apoptosis and proinflammatory cytokine secretion, and the fusion of phagosomes with lysosomes. Importantly, Rv3529c prevented the association of MyD88 with IRAK1. Indeed, it also associated with IRAK1. These results indicate the presence of molecular mimicry in the M. tuberculosis genome, which attenuates the protective immune responses by Mfs.
MATERIALS AND METHODS

Materials
Luria Bertani broth and Luria Agar, Middlebrook 7H9 broth and 7H11 Agar were purchased from Difco Laboratories (Franklin Lakes, NJ, USA), whereas BBL Middlebrook ADC and OADC Enrichment were procured from BD Biosciences (Franklin Lakes, NJ, USA). Ti Taq polymerase, 103 MgCl 2 buffer, dNTPs, and restriction enzymes Nco1 and Xho1, with fast digest green buffer, were procured from Thermo Fisher Scientific (Waltham, MA, USA). Abs to pERK, NF-kB, Bax, IAP, and GAPDH were procured from Santa Cruz Biotechnologies (Santa Cruz, CA, USA). mAbs to MyD88, TRAF-6, and IRAK1 were procured from Cell Signaling Technology (Danvers, MA, USA). DCFH-DA, TMB8, and EGTA, PKC inhibitor calphostin C, MAPK-ERK inhibitor U0126, and PMA were procured from Sigma-Aldrich (St. Louis, MO, USA). The concentrations of the inhibitors used were as follows: EGTA [3 mM], TMB8 [100 mM], calphostin C [0.1 mM], and U0126 [10 mM]. Annexin V-APC and ELISA kits were from eBioscience (San Diego, CA, USA). G-protein-coated sepharose beads were purchased from GE Healthcare (Waukesha, WI, USA) and Dynabeads M-270 streptavidin, FM4-64, and Lysotracker green were procured from Thermo Fisher Scientific.
Cloning and expression of Rv3529c
Primers (forward primer, 59-AAGCTTGCCATGGAAATGACTCGGCGTCCCGAT-39 and reverse primer, 39-GGCTCGAGGGTACCCAGCCCGGCGAACCGCT-59) specific to Rv3529c were designed with Primer3 software (Whitehead Institute for Biomedical Research, Cambridge, MA, USA), along with restriction sites procured from Sigma-Aldrich. PCR was performed on a Thermal Cycler (Bio-Rad Laboratories, Hercules, CA, USA). QIAquick Gel Extraction kit (Qiagen, Germantown, MD, USA) was used to extract the PCR amplicons. T4 DNA ligase and ligation buffer (Thermo Fisher Scientific) were used for overnight ligation of the amplicons to the pGEMT and pET28b vector (Sigma-Aldrich). The histidine-tagged protein Rv3529c was purified with Ni-NTA agarose beads (Qiagen) followed laboratory standardized procedures [9, 10] . Sequencing of the Rv3529c gene was confirmed after cloning.
Cell culture and stimulation
The human monocyte-Mf cell line THP-1 was maintained in RPMI-1640 medium supplemented with 10% FBS and 2 mM L-glutamine and was used throughout the study. Consistent with previous reports from our laboratory, THP-1 monocytes were differentiated into Mfs with PMA [9] . Unless otherwise mentioned, cells were stimulated with 15 mg/ml of recombinant Rv3529c, with or without ligands to various TLRs (Pam 3 Csk 4 for TLR2 and LPS for TLR4 at 1 mg/ml, imiquimod for TLR7 at 5 mg/ml, and CpG DNA for TLR9 at 5 mM), each for indicated times. For some experiments, cells were incubated with the indicated concentrations of inhibitors to various signaling molecules for 1 h before stimulation.
Mf culture from human PBMCs
Five milliliters of blood was drawn from healthy young adults, and the PBMCs were isolated with Ficoll Paque (GE Healthcare) and cultured in RPMI-1640 along with 10% autologous serum and human recombinant M-CSF (Thermo Fisher Scientific) at a concentration of 30 ng/ml. Cells were cultured for 7 d to allow differentiation before stimulation for the experiments, and the cells were fed with serum and M-CSF on d 3 and 5. The institutional human ethics committee of the Dr. BR Ambedkar Centre for Biomedical Research at the University of Delhi approved the study. Blood samples were collected from young adult, healthy volunteers with their understanding and consent.
Measurement of oxidative burst by flow cytometry and confocal microscopy Intracellular ROS levels were measured by flow cytometry, as described previously, using the redox-sensitive dye DCFH-DA [10] . THP-1-derived Mfs were stimulated with Pam 3 Csk 4 or LPS and Rv3529c for 1 h. Thirty minutes before the completion of the incubation period, cells were incubated with 10 mM DCFH-DA, while avoiding exposure to light. Cells were then washed thoroughly with RPMI-1640 medium and immediately acquired for analyses in FACS Calibur (BD Biosciences). The data were plotted and analyzed with CellQuest Pro software (BD Biosciences). For experiments with human PBMC-derived Mfs, ROS was measured by confocal microscopy. Briefly, cells were stimulated with Pam 3 CSk 4 in the presence and absence of Rv3529c for 1 h. Thirty minutes before the incubation period DCFH-DA was added to cells, and ROS was measured with a Nikon (Minato, Tokyo, Japan) C2 confocal microscope. Data were analyzed by NIS Elements Advanced Research software (Nikon).
Western blotting for signaling molecules
After the stipulated time for incubation, the cells were washed with ice-cold PBS and lysed in a buffer containing 10 mM HEPES (pH 7.9), 10 mM KCl, 0.1 mM EDTA, 0.1 M EGTA, 0.5% Nonidet P-40, and mammalian cell protease inhibitor cocktail (Sigma-Aldrich). The cell-lysis suspension was then centrifuged at 13,000 g for 5 min at 4°C. The supernatant was harvested as cytoplasmic extract. The pellet was further processed for lysis in a buffer containing 20 mM HEPES (pH 7.9), 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, and mammalian cell protease inhibitor cocktail, with intermittent vortexing. This suspension was then centrifuged at 13,000 g for 15 min at 4°C. The supernatant was collected and designated as the nuclear extract. Cytoplasmic or nuclear extracts (30 mg) were resolved on SDS-PAGE and subsequently transferred onto nitrocellulose membrane (Hybond C pure, GE Healthcare). The blotted membranes with the transferred proteins were then probed with (continued from previous page) ROS = reactive oxygen species, Tcp = TIR domain-containing protein, TIR = Toll-IL-1 receptor, TMB8 = 3,4,5-trimethoxybenzoic acid 8-(diethylamino) octyl ester, TRAF6 = TNF receptor-associated factor 6 primary Abs to various molecules, followed by probing with HRP-labeled secondary Abs. A parallel set of samples was run separately on SDS-PAGE and probed for GAPDH to ensure equal amount of loading for each sample. The blots were developed by chemiluminescence using the luminol reagent from Santa Cruz Biotechnology
Coimmunoprecipitation
Cytoplasmic extracts prepared as indicated above were incubated with Abs against the protein of interest at 4°C overnight on a rocker, which was followed by the addition of G-protein-coated sepharose beads, and binding was allowed for 3 h at 4°C on a rocker. The beads were washed and resolved on SDS-PAGE, followed by transfer to nitrocellulose membrane, and Western blot analysis was performed for the molecule of interest.
Biotinylation and biotin-streptavidin isolation
Rv3529c, Rv3416, and BSA were biotinylated using published protocols from the laboratory [9, 10] . PMA-treated THP-1 cells were stimulated with biotinylated Rv3529c conjugated to PE-streptavidin (15 mg/ml) for 1 h. Z-stack images were collected at 1-mm intervals to score for internalization of the protein using confocal microscopy (Nikon C2). For some experiments, biotinylated BSA, Rv3416, or Rv3529c was added to cytoplasmic extracts and incubated overnight at 4°C on a rocker. That procedure was followed by the addition of Dynabeads M-270 streptavidin, per the manufacturer's protocols, to isolate the biotinylated proteins from the cytoplasmic extract. The beads were separated magnetically and were resolved on SDS-PAGE, followed by transfer to nitrocellulose membrane for Western blot analysis of the indicated molecules.
Confocal microscopy for phagosome-lysosome fusion
PMA-treated THP-1 cells (0.5 3 10 5 /ml) were stimulated with 15 mg/ml Rv3529c for 24 h. Mycobacterium bovis BCG or M. tuberculosis H37Rv was labeled with FM4-64 dye for 2 min on ice, followed by thorough washes, as recently described [11] . Rv3529c-stimulated THP-1-derived Mfs were then infected with either 2 MOI of FM464-labeled M. bovis BCG or M. tuberculosis H37Rv for 4 h, with or without pretreatment with 2 mM of ionomycin for 45 min before infection. Cells were stained with Lysotracker Green to stain the lysosomes. Confocal imaging was performed with a Nikon A1 laser scan confocal microscope at 360 objective magnification, a numerical aperture of 1.4, and a refractive index of 1.5, with Plan Apo optics equipped with an argon laser, using excitation and emission wavelengths of 488 and 561 nm, respectively. Data were analyzed using the NIS Elements Advanced Research software.
Statistics
ANOVA was used to test for statistical significance. P , 0.05 was taken as a statistically significant difference.
RESULTS
Rv3529c shares similarity to MyD88 adaptor protein in the TLR pathway
Amino acid sequences of the 6 isoforms of human MyD88 were obtained from UniProt (http://www.uniprot.org). Each of them was subjected to local alignment with M. tuberculosis [1773 TaxId. National Center for Biotechnology Information (NCBI), Bethesda, MD, USA] Protein Data Bank database (http://www. rcsb.org) using NCBI PSI BLAST. MyD88 isoform 4 showed similarity with 2 M. tuberculosis proteins Rv2386c (salicylate synthase Mbti) and Rv3529c (sulfotransferase Stf1) but with a high E value. Other proteins showed gapped or dispersed alignment. However, on further examination of the alignment details of the Rv3529c, a short conserved domain with high similarity in the secondary structure within the death domain of MyD88 protein was found in the PDB database. The death domains of all the isoforms of MyD88 were found to be same. When the death domain of MyD88 was searched with BLAST against the M. tuberculosis (1773 TaxId) Protein Data Bank database again, sulfotransferase (Stf1) Rv3529c was picked with the same stretch of alignment seen previously but with a lower E value. Further, on aligning the complete sequence of all the isoforms of MyD88 with Rv3529c, significant alignment with an acceptable E value had a higher-percent identity and sequence similarity to the death domain (Supplemental Fig. S1A ). In our study, M. tuberculosis proteins that showed similarity with all or most of the isoforms for a given human TLR protein were given priority. Amino acid sequence similarity with the death domain of MyD88 was seen for both Rv3529c and Rv2386c at separate positions. However, Rv3529c showed complete secondary structure similarity at its aligning region with the death domain of MyD88, whereas Rv2386c showed a partial secondary structure similarity within its aligning region. Because structural similarity has an important role in recognition during protein interactions, that criterion was given priority. Because MyD88 interacts with IRAK1 and its death domain, it was hypothesized that the similarity of the Rv3529c protein from the pathogen might influence the function of the host protein, MyD88, and its interaction with other TLR pathway adapter proteins, such as IRAK1. Rv3529c is a putative sulfotransferase, and it is predicted to have a role in respiration and metabolism in M. tuberculosis.
Rv3529c inhibits TLR2-induced oxidative burst in Mfs
An early and major defense mechanism associated with Mfs is the mounting of oxidative burst upon challenge with pathogens or their antigens. This is achieved primarily by generating ROS. Therefore, we investigated whether Rv3529c would modulate TLR-induced ROS generation. We also ensured the purity of recombinantly expressed Rv3529c. The results are shown in Supplemental Fig. S1B . In addition, we also ensured that Rv3529c was taken up by Mfs and internalized. To that end, we biotinylated Rv3529c and monitored its uptake by Mfs with confocal microscopy. As shown in Supplemental Fig. S1C , Rv3529c was completely internalized within 1 h of incubation, indicating that it is readily taken up by Mfs. Next, THP-1-derived Mfs were stimulated with Pam 3 Csk 4 , a specific ligand for TLR2 [9] , in the presence or absence of Rv3529c, and ROS was measured by FACS. As shown in Fig. 1A , stimulation of TLR2 (with Pam 3 Csk 4 ) increased ROS levels. In contrast, stimulation with Rv3529c did not significantly modulate basal levels of ROS (Fig. 1B) . However, costimulation with the TLR2 ligand and Rv3529c significantly inhibited ROS generation (Fig. 1C) .
To investigate whether the inhibition of ROS by Rv3529c was specific to TLR2, we investigated its effects on TLR4, TLR7, and TLR9. To that end Mfs were stimulated with LPS (TLR4 ligand), imiquimod (TLR7 ligand), and CpG DNA (TLR9 ligand) in the presence and absence of Rv3529c. As shown in Supplemental Fig.  S2A , Rv3529c also significantly inhibited TLR7-induced ROS generation and marginally inhibited TLR4-and TLR9-induced ROS generation. Further, we also investigated whether Rv3529c could modulate ROS in the presence of M. bovis BCG. As shown in Supplemental Fig. S2B infection with BCG decreased basal levels of ROS. Coincubation with BCG along with Rv3529c marginally decreased ROS levels. This could be due to the BCG triggering multiple receptors on the Mfs; the combined effect of which would be a decrease in basal levels of ROS, and costimulation with Rv3529c would not add to that decrease, possibly because of saturation.
Next, to show that the results were not restricted to cell lines, similar experiments were performed with Mfs derived from human PBMCs. Mfs derived from human PBMCs were stimulated with Pam 3 Csk 4 in the presence or absence of Rv3529c. The cells were stained with DCFH-DA, and ROS was observed by confocal microscopy. As shown in Supplemental 
Inhibition of ROS by Rv3529c is dependent on route of calcium entry
To identify molecular constituents contributed toward inhibition of TLR-induced ROS by Rv3529c, we next investigated the role of key signaling second messengers that are known to have a determinant role in TLR pathways. To that end, cells were incubated with biopharmacologic inhibitors that prevent calcium release from intracellular stores or calcium influx from an external medium and inhibitors to PKC and ERK-MAPK, followed by stimulation with Pam 3 Csk 4 , in the presence or absence of Rv3529c. Recent reports from our laboratory have identified significant roles for these signaling intermediates in modulating defense responses of Mfs in M. tuberculosis [9] [10] [11] [12] . As shown in Fig. 1D and E, inhibiting MAPK-ERK and PKC, respectively, further inhibited ROS levels upon Pam 3 Csk 4 and Rv3529c costimulation. This indicated a positive role for PKC and MAPK-ERK in modulating TLR2-induced oxidative burst. Inhibition of calcium release from intracellular stores (Fig. 1F ) also resulted in further inhibition of ROS beyond that obtained with Rv3529c and Pam 3 Csk 4 costimulation, suggesting a positive role for intracellular calcium release in mediating ROS generation. However, and interestingly, inhibition of calcium influx from the external medium (Fig. 1G) prevented the inhibition of ROS upon Rv3529c and Pam 3 Csk 4 costimulation, and the levels were similar to those obtained upon stimulation of TLR2. This indicated a negative effect for calcium influx in mediating TLR2-induced ROS generation. These results also indicated that the route of calcium entry differentially regulated TLR2-induced ROS generation. Further, it also pointed to a role for calcium routing in the inhibitory responses mediated by Rv3529c.
Rv3529c modulates TLR2-mediated activation of pERK and NF-kB
To identify the functional relevance of Rv3529c with respect to its similarity to MyD88, the next set of experiments focused on monitoring the key activation markers of the TLR pathway. To that end, we chose to investigate the phosphorylation of ERK-MAPK, as well as nuclear translocation of NF-kB. Therefore, THP-1-derived Mfs were stimulated with Pam 3 Csk 4 in the presence and absence of Rv3529c for the indicted times. Cytoplasmic extracts and nuclear extracts were prepared and Western blot analysis for pERK and NF-kB p65, respectively, were performed. As shown in Fig. 2 , Rv3529c significantly inhibited TLR2-mediated phosphorylation of ERK and the activation of NF-kB. These results indicate that Rv3529c inhibited the activation of 2 key molecules in the TLR pathway.
Rv3529c inhibits production of proinflammatory cytokines
Cytokines are secreted by Mfs in response to different kinds of antigenic/pathogenic stimulations. Although IFN-g, IL-6, and IL-17A promote proinflammatory responses, IL-10 and TGF-b promote suppressor responses. Therefore, to investigate whether Rv3529c would modulate the cytokine profiles of Mfs after TLR2 stimulation, the levels of the above cytokines were investigated after stimulation with TLR2 in the presence or absence of Rv3529c. As shown in Fig. 3 , stimulation of TLR2 alone expectedly increased the levels of proinflammatory cytokines IFN-g, IL-6, and IL-17A, with no significant changes in the levels of suppressor cytokines, such as IL-10 and TGF-b. However, costimulation with Pam 3 Csk 4 , along with Rv3529c, significantly decreased the expression of IFN-g, IL-6, and IL-17A as well as significantly increasing the levels of IL-10 and TGF-b. These results clearly point toward a role for Rv3529c in enhancing suppressor responses from Mfs that favor the pathogen. Similar results were obtained with PBMC-derived Mfs. A significant decrease in the levels of IFN-g and a marginal decrease in IL-6 levels after costimulation with Pam 3 Csk 4 and Rv3529c were observed (Supplemental Fig. S3B ), along with a significant increase in IL-10 levels.
To address the increase in the levels of IL-10 and TFG-b in light of the diminished TLR2 responses, we investigated the ability of Rv3529c to bind to THP1. Cells were incubated with fluorescence-labeled Rv3529c at 4°C for 1 h. Inhibition experiments showed that Rv3529c bound to TLR4, and the binding was reduced in the presence of LPS (Supplemental Fig. S4 ). Interestingly, Rv3529c showed increased binding to THP1 in the presence of TLR2 ligand. This enhanced binding was reversed in the additional presence of LPS. These data clearly showed that Rv3529c bound to TLR4. TLR4 mediates IL-10 responses by both MyD88-dependent and -independent pathways [13, 14] . Combining that information with above data is indicative of Rv3529c mediating proinflammatory responses from TLR2 and inducing suppressor responses from TLR4.
Rv3529c modulates expression of and associations between MyD88 with IRAK1
We next investigated whether Rv3529c interferes with the association of the TLR adaptor protein MyD88 and IRAK1. To that end, Mfs were stimulated with Pam 3 Csk 4 and Rv3529c for 1 h, and cytoplasmic extracts were used to immunoprecipitate MyD88, followed by Western blot analysis for IRAK1 (Fig. 4A) . Conversely, IRAK1 was immunoprecipitated after by Western blot analysis for MyD88 (Fig. 4B) . As shown in Fig. 4A and B, Rv3529c significantly inhibited the TLR2-induced association of MyD88 and IRAK1. These results indicate that Rv3529c inhibits the association of MyD88 and IRAK1 because of its similarity with MyD88. This could account for the observed effects on ROS, ERK-MAPK phosphorylation, NF-kB activation, and cytokine profiles. Interestingly, we also observed a gross reduction in the expression levels of IRAK1 and MyD88, but not TRAF6, in Mfs stimulated with Rv3529c for 24 h, which was independent of TLR2 stimulation (Supplemental Fig. S5A ). We ascertained that the levels of IRAK1 and MyD88 remained unaffected at 1 h of stimulation with Pam 3 Csk 4 and Rv3529c (Supplemental Fig. S5B ), indicating that the decreased association of MyD88 with IRAK1 and vice versa was not due to decreased levels of those 2 molecules. Further, Rv3529c inhibited the interaction of MyD88 and IRAK1 in a dose-dependent manner (Fig. 4C) . Similar to THP1, Mfs derived from human PBMCs also displayed a lesser association of MyD88 with IRAK1 in the presence of Pam 3 Csk 4 and Rv3529c (Supplemental Fig. S6A) .
Next, we explored the direct association of Rv3529c with IRAK1. To that end, cytoplasmic extracts of unstimulated Mfs were incubated with biotinylated Rv3529c, followed by pull-downs with streptavidin-coated magnetic beads. The beads were later subjected to SDS-PAGE, followed by Western blot analysis for IRAK1. To avoid spillover of the beads from one lane onto another, the samples were loaded with a lane left blank between each sample. As shown in Fig. 4D , Rv3529c positively associated with IRAK1, whereas no detectable associations were observed with either BSA (Fig. 4D ) or biotinylated Rv3416 (Fig. 4E) . Our previous work has identified Rv3416c (also known as WhiB3) expressed inside infected Mfs later after infection. Characterization of Rv3416 in our laboratory pointed toward its role in promoting suppressor responses and promoting pathogen survival in infected cells [15] . Rv3416 was taken as a control to confirm the specificity of Rv3529c in its association with IRAK1. These results once again point toward sequestration of IRAK1 by Rv3529c with determinant effects on Mf defense responses to M. tuberculosis.
Rv3529c blocks TLR2-mediated apoptosis of Mfs
A key strategy used by M. tuberculosis to establish long-term infections in Mfs is to prolong its survival by inhibiting apoptosis. Having observed the proximal effects of Rv3529c on ROS generation and phosphorylation and the activation of ERK-MAPK and NF-kB pathways, we next explored its role in modulating the defense responses of Mfs, such as apoptosis. Our recent reports [9, 10] have established the role of M. tuberculosis proteins in modulating apoptosis and autophagy in Mfs. We first investigated the levels of phosphatidylserine on the cell surface by Annexin V staining. As shown in Fig. 5A , and consistent with our earlier report [9] , Pam 3 Csk 4 did not significantly modulate Annexin V. However, Rv3529c marginally reduced Annexin V levels. Importantly, cells costimulated with Rv3529c and Pam 3 Csk 4 synergistically down-modulated Annexin V levels on Mfs. We extended those observations by monitoring the expression levels of key proapoptotic and antiapoptotic markers. Rv3529c aids inhibition of phagosome-lysosome fusion by M. bovis BCG and M. tuberculosis
One of the most successful strategies of M. tuberculosis is to prevent the fusion of phagosomes with lysosomes for long-term persistence and also to prevent loading of antigenic peptides onto MHC-class II. We, therefore, investigated the ability of Rv3529c to inhibit phagolysosome fusion. Because it has been reported that BCG also inhibits phagolysosome fusion [16] , we first devised a strategy to induce phagolysosome fusion in M. bovis BCG-and M. tuberculosis H37Rv-infected Mfs. To that end, we infected Mfs with FM64-labeled M. bovis BCG in the presence of calcium ionophore ionomycin to facilitate calcium influx inside the cells. It has been reported that an increase in calcium ion concentration inside Mfs increases phagosome-lysosome fusion and that mycobacteria depletes Ca 2+ concentration in Mfs to prevent this fusion [17] . We have also recently demonstrated the role of voltage-gated calcium channel regulated calcium influx in regulating phagolysosome fusion [11] . As shown in Fig. 6 , appreciable levels of phagosome-lysosome fusion were not observed upon infection of Mfs with BCG (Fig. 6A) or M. tuberculosis H37Rv (Fig. 6B) . However, M. bovis BCG or M. tuberculosis H37Rv infection in the presence of ionomycin significantly allowed phagosome-lysosome fusion. In contrast pretreatment of Mfs with Rv3529c significantly inhibited phagolysosome fusion mediated by ionomycin in both M. bovis BCG-and M. tuberculosis H37Rv-infected Mfs. A similar inhibition of fusion of phagosomes with lysosomes was observed in PBMC-derived Mfs (Supplemental Fig. S6B ). These results clearly point toward a role for Rv3529c in inhibiting phagosome-lysosome fusion, thus favoring prolonged pathogenic survival.
Rv3529c promotes the survival of M. bovis BCG in infected Mfs
Finally, we investigated whether Rv3529c would modulate the bacterial burden inside infected Mfs. To that end, Mfs were incubated with Rv3529c, followed by infection with M. bovis BCG for 48 h at 2 MOI. CFUs were scored for relative bacterial numbers. As shown in Fig. 7 , incubation with Rv3529c significantly increased BCG CFUs, indicating a direct role of Rv3529c in regulating mycobacterial survival within Mfs.
DISCUSSION
Successful pathogens employ multiple and often complementing strategies to attenuate defense responses mounted by the host by expressing proteins that inhibit protective immune responses. For example, the 19-kDa lipoprotein of M. tuberculosis inhibits IFN-g-mediated responses via the TLR2 pathway [18] . It also inhibits the expression of CIITA4, thereby inhibiting MHC-class II-mediated CD4 + T cell responses [19] . Our laboratory has identified a number of proteins/antigens that mediate suppressor responses [20] [21] [22] [23] . In addition, we identified proteins/ antigens that are expressed inside Mfs as a function of infection time [15] . These early and late-expressed proteins inhibit various protective responses, including oxidative burst and nitric oxide secretion as well as proinflammatory cytokine expression [15] . Interestingly, these proteins complement each other in mediating immune suppression such that pathways targeted by proteins expressed early during infection are not targeted by the lateexpressed proteins [15] . Further characterization of these proteins identified their role in modulating the expression of voltage-gated calcium channel [12, 24] immune responses during HIV-M. tuberculosis coinfection [9] and neddylation [10] . In addition, many pathogens, including bacteria, viruses, and parasites, are known to harbor sequences in their proteins that mimic specific signaling domains of proteins in various pathways in cells. Molecular mimicry has been discovered to be a potent immune-evasion mechanism in viruses. Seventeen orthopoxviruses from 3 major species (vaccinia, cowpox, and camelpox viruses), upon infecting mammalian cells, are known to produce soluble receptors of IFN-g, which bind to IFN-g and prevent its interaction with the receptor, thereby attenuating the antiviral effects mediated by that cytokine [25] . Cowpox viruses are also known to produce a soluble receptor of TNF to prolong their survival in infected cells [25] . The B15R gene of vaccinia virus produces a soluble receptor of IL-1b to evade the host's immune system. Deletion of B15R accelerates the appearance of symptoms of the disease [26] . Further, EBV encodes a homolog of IL-10, which is effective in limiting its own replication, and thus helps it to maintain the nonpathogenic and stable virus carrier state in host cells [27] . Human herpes virus 8 is known to encode a homolog of human IL-6, which has a highly conserved receptor-binding domain, suggesting its role in IL-6 deregulation and its involvement in human herpes virus 8 pathogenesis [28] . In the human cytomegalovirus genome, an open reading frame US28 has been found with homology to human chemokine receptors. Its product, pUS28, binds to several human CC chemokines, including MCP-1, MIP-1a, RANTES, and the CX3C chemokine fractalkine with high affinity [29] . Vaccinia virus protein A49 is an inhibitor of NF-kB and has a closely related counterpart in variola virus [30] . A49 blocks NF-kB activation by molecular mimicry and contains a motif conserved in IkBa, thus preventing p65 nuclear translocation and downstream proinflammatory effects [30] . Possibilities of hijack of the host genes and horizontal gene transfer between host and parasite, mediated by viruses, are being examined. Examples of exploitation of host immune responses by parasites have also been found, wherein parasites efficiently use the host cytokines as their growth factors. These have often been named as virokines, viroreceptors, and helminth-pseudocytokines [3] Keeping that in mind, we investigated whether the M. tuberculosis genome would code for proteins having similarities to mammalian proteins involved in innate immunity. Our search identified Rv3529c as a probable protein having homology to TLR-signaling intermediate MyD88. Results show that Rv3529c effectively attenuated TLR2 signaling. That was reflected in the extent of oxidative burst, phosphorylation of MAPK-ERK, and activation of NF-kB. The proximal effects on these molecules had a distal outcome wherein the levels of proinflammatory cytokines IFN-g, IL-6, and IL-17A were significantly inhibited. Concomitantly, the levels of suppressor cytokines IL-10 and TGF-b were up-regulated. Although IFN-g and IL-17 are important for control of M. tuberculosis infection [31] [32] [33] , high levels of IL-10 and TGF-b increase susceptibility to M. tuberculosis infection [32, 34] .
Importantly and significantly, Rv3529c prevented the association of MyD88 with IRAK1. Further, Rv3529c also physically associated with IRAK1, thus effectively mimicking MyD88. However, Rv3416, a protein that has been extensively characterized in our laboratory, and induces suppressor responses [9, 13] did not associate with IRAK1. These results clearly point toward a direct role for Rv3529c in mediating immune suppression via directly interfering with the TLR2 pathway and identify yet another strategy employed by successful pathogens to thwart protective immune responses. Further characterization of Rv3529c-mediated suppressor responses showed that Rv3529c prevented apoptosis by increasing the expression levels of a key antiapoptotic protein and reducing the expression of a signature proapoptotic protein. Finally, Rv3529c significantly inhibited the fusion of phagosome and lysosome, thereby ensuring the long-term survival of the mycobacteria inside the Mfs.
Overall, our results point toward the existence of multiple strategies by which M. tuberculosis, individually and collectively, inhibit protective responses and create a niche for the pathogen for long-term survival. We are in the process of identifying detailed mechanisms involved during the immune suppression by Rv3529c, which include its interactions with other signaling intermediates as well as epigenetic modulations of key genes mediating protective responses. AUTHORSHIP U.B. and K.N. proposed the hypothesis and designed the experiments. U.B., A.C., P.G., B.T., K.B., and S.P. performed the various experiments. U.B., R.R., V.B., Y.S., P.M., and K.N. analyzed the data. U.B., K.B., V.B., P.M., and K.N. wrote the manuscript.
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